Godavari Drugs has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 13th day of August, 2025, to consider and approve the unaudited standalone financial results of the Company for the first quarter ended 30th June, 2025. Further, the company has informed that the 37th Annual General Meeting (‘AGM’) of the Company, originally scheduled to be held on 28th August, 2025, has been rescheduled. The revised date, time, and venue/mode of the AGM shall be intimated in due course. As informed earlier, the trading window for dealing in securities of the Company for designated persons and their immediate relatives, which has been closed effective 1st July, 2025, shall remain closed till 15th August, 2025. The trading window shall reopen on 16th August, 2025.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1818.35 |
| Dr. Reddys Lab | 1276.50 |
| Cipla | 1328.10 |
| Zydus Lifesciences | 907.25 |
| Lupin | 2335.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: